Two Names in the News (Stocks Under $10 $)
A pair of model portfolio names are trading higher today -- one on takeover rumors and the other on new analyst coverage.
12:32PM 12/15/09
Biotech Calendar: Upcoming FDA Dates
A quick and dirty guide to the expected regulatory news from the FDA through June 2010.
04:25PM 12/14/09
Stocks Under $10 Weekly Summary (Stocks Under $10 $)
This week, we freed up some cash in anticipation of further buying opportunities for the model portfolio.
04:34PM 12/11/09
NEW YORK (TheStreet) -- David Peltier, portfolio manager of Stocks Under $10, reveals his three top stock picks for 2010 in retail, mining and health care.
06:00AM 12/10/09
Stocks Under $10 Weekly Summary (Stocks Under $10 $)
In a week that ended with a positive jobs number, we continued to research potential new names for the model portfolio.
04:36PM 12/04/09
Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Stocks Under $10 Weekly Summary (Stocks Under $10 $)
We focused on researching new names for the model portfolio this week and used Friday's pullback to add shares to one holding.
02:17PM 11/27/09
Poniard Finds Cash to Keep Lights On: BioBuzz
Poniard faces a cash-crunch situation after a failed drug test last week.
12:59PM 11/23/09
A Pair of Updates (Stocks Under $10 $)
Two model portfolio names are in the news today amid chatter on an obesity-drug study and a takeout rumor.
12:28PM 11/23/09
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
Shareholders are on the hook for a generous loan repayment to Cel-Sci's founder.
10:14AM 11/23/09
FDA Issues New Obesity Drug Heart Warning: BioBuzz
Safety of Abbott's Meridia may heighten concerns for all weight-loss drugs
08:15AM 11/23/09
Stocks Under $10 Weekly Summary (Stocks Under $10 $)
We put some cash to work this week as the model portfolio's benchmark, the Russell 2000, fell for four straight days.
04:54PM 11/20/09
Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
06:01AM 11/20/09
Poised for a Purchase (Stocks Under $10 $)
This pharmaceutical name is trading lower on the session, but we will continue to monitor the price action before taking action.
11:59AM 11/19/09
'Fast Money' Recap: Reversing the Weak Dollar Trade
The trading panel discussed the trade and what it would take to turn it around.
08:06PM 11/18/09



Connect with TheStreet